Startup | February 27, 2024
Pfizer joins hands with NIPER (Ahmedabad) to support Healthcare Innovation in India
Pfizer INDovation program partners with NIPER Ahmedabad to incubate healthcare startups
Pfizer INDovation program partners with NIPER Ahmedabad to incubate healthcare startups
The acquisition of Aiolos includes AIO-001, a potentially best-in-class, long-acting antithymic stromal lymphopoietin (TSLP) monoclonal antibody
Minzoya Tablets are indicated for use by females of reproductive potential to prevent pregnancy
he lower sales in the current quarter are mainly on account of a one?time impact on the company’s India business
The company is strongly committed to enhancing customer satisfaction and catering to the discerning needs of renowned pharmaceutical companies
The company is committed to a new category development in areas like adult Immunization with products like Shingrix to make a positive impact to the lives of the patients in India
Developed by Pfizer, Abrocitinib has received marketing authorization from the Central Drugs Standard Control Organization (CDSCO) in India
This alliance brings together drug innovation capabilities of Glenmark and Ichnos to develop cutting-edge therapies for the treatment of hematological malignancies and solid tumors
Glenmark will be responsible for further developing, registering, and commercializing Envafolimab in India, Asia Pacific, Middle East and Africa, Russia, CIS, and Latin America
The initiative is a response to the rising incidents of heart attacks and cardiac arrests in the state
Subscribe To Our Newsletter & Stay Updated
